Telomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Telomir Pharmaceuticals (TELO) operate in?

Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Telomir Pharmaceuticals Stock (NASDAQ: TELO) stock price, news, charts, stock research, profile.

Open	$4.17
Close	-
Volume / Avg.	69.33K / 196.02K
Day Range	$4.04 - $4.34
52 Wk Range	3.11 - 11.20
Market Cap	$119.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	6.54%
Days to Cover	17.19

Recent News

Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration

Telomir Pharmaceuticals' Telomir-1 stabilizes Silver(II) for medical use, addressing instability issues in antimicrobial treatments and wound care solutions.

Vandana Singh

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease

Telomir-1 shows potential as a treatment for Wilson's disease and related disorders, with promising preclinical results and potential for orphan drug designation.

Akanksha Bakshi

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$4.17
Close	-
Volume / Avg.	69.33K / 196.02K
Day Range	$4.04 - $4.34
52 Wk Range	3.11 - 11.20
Market Cap	$119.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	6.54%
Days to Cover	17.19

About Telomir Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Telomir Pharmaceuticals (TELO) stock?

You can purchase shares of Telomir Pharmaceuticals (NASDAQ:TELO) through any online brokerage.

View our list of the best stock brokerages

Who are Telomir Pharmaceuticals (TELO) competitors?

Other companies in Telomir Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Nutriband (NASDAQ:NTRB) and CNS Pharma (NASDAQ:CNSP).

What is the forecast, or price target, for Telomir Pharmaceuticals (TELO) stock?

There is no analysis for Telomir Pharmaceuticals to provide a consensus price target.

What is the current price for Telomir Pharmaceuticals (TELO)?

The stock price for Telomir Pharmaceuticals (NASDAQ: TELO) is $4.01 last updated February 21, 2025 at 10:18 AM EST.

Does Telomir Pharmaceuticals (TELO) pay a dividend?

There are no upcoming dividends for Telomir Pharmaceuticals.

When is Telomir Pharmaceuticals (NASDAQ:TELO) reporting earnings?

Telomir Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Telomir Pharmaceuticals (TELO) going to split?

There is no upcoming split for Telomir Pharmaceuticals.

What sector and industry does Telomir Pharmaceuticals (TELO) operate in?

Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Telomir Pharmaceuticals

Telomir Pharmaceuticals (TELO) Forecast